Ebitda Cambiamento Data
AbbVie USD 6.75B 433M 2023-09
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Amgen USD 3.66B 713M 2023-12
Astellas Pharma JPY 35.75B 32.55B 2023-09
AstraZeneca USD 3.43B 412M 2023-09
Biogen USD 652.1M 241.8M 2023-12
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bluebird Bio USD -83657000 670K 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Esperion Therapeutics USD -27507000 9.5M 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
GlaxoSmithKline GBP 3.17B 729M 2023-09
Incyte USD 226.99M 9.73M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
J&J USD 6.46B 1.51B 2023-12
Kyowa Hakko Kirin JPY 42.5B 28.88B 2023-09
Merck USD 7.51B 11.02B 2023-09
Moderna USD 209M 1.97B 2023-12
Neurocrine Biosciences USD 146.7M 68M 2023-09
Opthea USD -71305640 6.5M 2023-06
Pfizer USD 1.14B 2.05B 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Roche Holding CHF 12.35B 1.92B 2023-06
Sarepta Therapeutics USD -9914000 112.81M 2023-09
Teva Pharmaceutical Industries USD 1.14B 13M 2023-09
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
United Therapeutics USD 277.4M 62.9M 2023-12
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Regeneron Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.